Finward Bancorp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Finward Bancorp's PFE Position: Q3 2026 in Review
Finward Bancorp reduced its Pfizer (PFE) stake by 3.3% in Q3 2026, selling an estimated $9.9K and leaving 11,040 shares worth $315K. The position accounts for 0.23% of the portfolio, ranked #82.
Finward Bancorp first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $352K in Q4 2024. 648 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Finward Bancorp held 11,040 shares of Pfizer worth $315K as of Q3 2026.
- Finward Bancorp sold 372 Pfizer shares in Q3 2026, an estimated $9.9K.
- Pfizer made up 0.23% of Finward Bancorp's portfolio in Q3 2026, its #82 holding.
- Finward Bancorp first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- Finward Bancorp's Pfizer position peaked at $352K in Q4 2024.
- 648 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Finward Bancorp's 13F filing for Q3 2026, filed 14 Oct 2026.